DUAVIVE 0,45 mg/20 mg Tabletten mit veränderter Wirkstofffreisetzung
Recall
|
Medicines
|
25/05/2020
The marketing authorisation holder informed its customers on May 25, 2020 that the dissolution of an active substance may be slowed down and therefore the therapeutic effect may be delayed. So the affected batch is recalled.
| Name of the medicinal product | DUAVIVE 0,45 mg/20 mg Tabletten mit veränderter Wirkstofffreisetzung |
|---|---|
| Marketing authorisation number(s) | EU/1/14/960/001 |
| CIP code | 4481048 |
| Marketing authorisation holder | Pfizer Europe MA EEIG |
| Batch number(s) | AR3686 |
| Classification of the recall | 3 |
| Depth of recall | Wholesalers |
| BASG reference number | INS-640.001-3205 |
Further inquiry note
Page last modified:
25/05/2020